4.5 Article

Strategies for selective priming of memory B cells

Journal

IMMUNOLOGY LETTERS
Volume 109, Issue 2, Pages 93-100

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.imlet.2007.01.010

Keywords

memory B cell; vaccine; adjuvant; TLRs; B cell differentiation

Categories

Funding

  1. NCI NIH HHS [R01 CA108896] Funding Source: Medline
  2. NIAID NIH HHS [R37 AI026296, R01 AI026296, AI26296] Funding Source: Medline

Ask authors/readers for more resources

Long-term humoral immunity elicited by pathogens and vaccines alike relies upon the generation of both memory B cells (B-mem) and long-lived plasma cells (PCs). Virtually all vaccine formulations induce the concomitant emergence of both B-mem and PCs, suggesting that the emergence of these two differentiated B cells subsets is commonly controlled. Evidence presented shows specific Toll-like receptor (TLR) agonists coupled with soluble protein antigen (sAg) can selectively induce the expansion of antigen specific B-mem in the absence of PC generation. The co-administration of either TLR 3 or 9 agonists with sAg induced germinal centre (GC) formation, antigen-specific B-mem, but failed to substantively induce the generation of long-lived bone marrow (BM) PCs. Upon re-challenge, high levels of PCs were induced with concomitant high titres of antigen-specific serum IgG. Hence, vaccines can be developed that can prime and protect the host to subsequent infectious agents without initial, high levels of antibody production. Furthermore, these studies suggest that the signals that govern the expansion and differentiation of B-mem can be uncoupled from those that induce long-lived BM PCs. (c) 2007 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available